FNDC5 and Insulin resistance: Fibronectin type III domain containing 5 (FNDC5) is known to attenuate insulin resistance, and improves glucose and lipid metabolism 56-58, while increased miR-135a-5p in the EVs of SHR promotes VSMCs proliferation via inhibiting FNDC5 expression in WKY and SHR 26,59.